Akebia Therapeutics (AKBA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful ...

List today: Pharming Group N.V. PHAR: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current ...

Despite a 50% share price drop, I maintain Volaris as a Strong Buy due to its deep undervaluation and long-term growth ...

With potentially higher tariffs and interest rates back in the news, growth stocks will likely take a hit in the short term.

These five top Buy-rated dividend stocks were among S&P 500's top performers so far this year and still offer strong total ...

IDEXX Laboratories benefits from strong pet care trends, new platform adoption, and a high-margin recurring model that drives ...

Hagerty, Inc. (HGTY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Indeed, AMZN isn’t just a run-of-the-mill strong buy tech stocks. Rather, it’s a unanimous strong buy based on 29 analysts. Overall, their average price target lands at $152.52, implying ...

We used Finviz and Tipranks to make a list of 35 strong buy stocks. We then selected the top 10 stocks with the highest analyst upside potential as of March 12, 2025.

List today: Cronos Group Inc. CRON: This cannabinoid company has seen the Zacks Consensus Estimate for its current year ...